FDA, Drugmakers Urge 5th Circ. To Allow Abortion Pill By Mail
By Hailey Konnath · July 16, 2026, 10:22 PM EDT
The U.S. Food and Drug Administration and the makers of the abortion medication mifepristone have urged the Fifth Circuit not to reinstate an in-person dispensing requirement, arguing that doing so would...
To view the full article, register now.